Ikarian Capital, LLC A Tyr Pharma Inc Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.63 - $5.61 $97,354 - $207,665	-37,017 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.75 - $7.54 $9,352 - $14,846	1,969 Added 5.62%	37,017 $197,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $3.84 Million - $5.01 Million	-527,198 Reduced 93.77%	35,048 $262,000
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $1.11 Million - $3.27 Million	262,246 Added 87.42%	562,246 $5.11 Million
Q1 2021 May 17, 2021	SELL	$3.53 - $8.06 $353,000 - $806,000	-100,000 Reduced 25.0%	300,000 $1.34 Million
Q4 2020 Feb 12, 2021	BUY	$3.07 - $4.66 $1.23 Million - $1.86 Million	400,000 New	400,000 $1.55 Million

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.